BSG and colonic neoplasm: Blocking CD147 with a targeted monoclonal antibody or silencing CD147 by siRNA resulted in the inhibition of the proliferation, invasiveness, angiogenesis, and metastatic potential of colon cancer cells and malignant melanoma cells [17, 96, 97].